If the president really wants to put American patients first, he should consider putting this executive order back in the drawer from which it came.
Last week, President Donald Trump revived one of the most ill-conceived health policy ideas of his first term.
Via a new executive order, he’s directed his administration to deliver “most-favored-nation prescription drug pricing to American patients.”
The idea is to bring other developed countries’ lower drug prices to the United States — by jawboning pharmaceutical companies into complying or taking some sort of administrative action to forcibly cap prices if they won’t.
The order is a distraction.
The president can’t bring about lower drug prices by fiat.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.
Trump’s ‘Most Favored Nation’ Drug Plan Doesn’t Favor Americans
Sally C. Pipes
If the president really wants to put American patients first, he should consider putting this executive order back in the drawer from which it came.
Last week, President Donald Trump revived one of the most ill-conceived health policy ideas of his first term.
Via a new executive order, he’s directed his administration to deliver “most-favored-nation prescription drug pricing to American patients.”
The idea is to bring other developed countries’ lower drug prices to the United States — by jawboning pharmaceutical companies into complying or taking some sort of administrative action to forcibly cap prices if they won’t.
The order is a distraction.
The president can’t bring about lower drug prices by fiat.
Read the entire Newsmax column here.
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.